These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10278276)

  • 1. Peoria hospital cries 'antitrust' as rival signs preferred provider pact.
    Franz J
    Mod Healthc; 1984 Oct; 14(13):94, 96. PubMed ID: 10278276
    [No Abstract]   [Full Text] [Related]  

  • 2. NDHA (North Dakota Hospital Association) settles on antitrust suit.
    Burda D
    Mod Healthc; 1989 Feb; 19(5):6. PubMed ID: 10291672
    [No Abstract]   [Full Text] [Related]  

  • 3. An assessment of the anticompetitive effects of preferred provider organizations.
    Greaney TL; Sindelar JL
    Inquiry; 1987; 24(4):384-91. PubMed ID: 2961699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why the feds drove these doctors out of business.
    Hung K
    Med Econ; 1985 Apr; 62(7):92-4, 99, 102 passim. PubMed ID: 10278314
    [No Abstract]   [Full Text] [Related]  

  • 5. Preferred provider organizations: an antitrust warning.
    Sandler AL
    Group Pract J; 1987; 36(6):41-2, 44. PubMed ID: 10284861
    [No Abstract]   [Full Text] [Related]  

  • 6. Perspectives. PPOs face antitrust problems.
    Wash Rep Med Health; 1984 Nov; 38(44):suppl 4p. PubMed ID: 10268861
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitrust and the new competition in health care: excerpts.
    Ginsburg DH
    Med Prod Sales; 1986 Apr; 17(4):39-42. PubMed ID: 10276459
    [No Abstract]   [Full Text] [Related]  

  • 8. PPOs facing potential antitrust worries.
    Tarnoff S
    Bus Insur; 1985 Jul; 19(29):16, 20. PubMed ID: 10271746
    [No Abstract]   [Full Text] [Related]  

  • 9. The development of preferred provider organizations and its antitrust implications.
    Maram BS
    J Med Pract Manage; 1985 Oct; 1(2):130-5. PubMed ID: 10281825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Planning PPOs to minimize antitrust risk.
    Clanton DA
    Hospitals; 1985 Mar; 59(5):96, 98. PubMed ID: 3972373
    [No Abstract]   [Full Text] [Related]  

  • 11. More private, less government PPA antitrust action.
    Burda D
    Hospitals; 1987 Feb; 61(3):52. PubMed ID: 3804258
    [No Abstract]   [Full Text] [Related]  

  • 12. Reducing antitrust liability after Maricopa.
    Walsh JH; Feller H
    GHAA J; 1986; 7(2):57-74. PubMed ID: 10280126
    [No Abstract]   [Full Text] [Related]  

  • 13. Court: Indiana Blues may adopt PPO plan without antitrust scrutiny.
    Allen HS; Rothschild IS
    Health Law Vigil; 1986 Apr; 9(8):4-5. PubMed ID: 10278389
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternative delivery systems are focus of antitrust scrutiny.
    Scammon DL; Fuller DA; Sheffet MJ
    J Health Care Mark; 1987 Jun; 7(2):77-81. PubMed ID: 10282715
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitrust charges fail to slow PPA action by insurer.
    Burda D
    Hospitals; 1986 Apr; 60(8):68-70. PubMed ID: 3754236
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitrust implications of joint negotiations with third party payers.
    Rainer JM
    Top Health Care Financ; 1986; 13(2):79-85. PubMed ID: 3810649
    [No Abstract]   [Full Text] [Related]  

  • 17. Are PPOs a competitive force or antitrust risk?
    Enders RJ
    Healthc Financ Manage; 1986 May; 40(5):52-60. PubMed ID: 10276171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FTC and provider-controlled PPO price negotiations.
    Miles JJ
    Health Law Vigil; 1988 Jan; 11(3):6-10. PubMed ID: 10285716
    [No Abstract]   [Full Text] [Related]  

  • 19. Can provider antitrust suits against payers be successful?
    Enders RJ
    Healthc Financ Manage; 1986 Jun; 40(6):72-80. PubMed ID: 10276682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operational and legal implications of preferred provider organizations.
    Adams-Ryan D; Peddecord KM; Root GL
    Hosp Health Serv Adm; 1985; 30(3):44-57. PubMed ID: 10271468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.